BioSyntech, Inc.
BSYI · OTC
3/31/2009 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -85.1% | 12.5% | 295.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.8% | 62.8% | 63.1% | 65.2% |
| R&D Expenses | $6 | $6 | $5 | $3 |
| G&A Expenses | $3 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $4 | $4 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | -$0 | -$0 | $0 |
| Operating Expenses | $11 | $9 | $8 | $6 |
| Operating Income | -$11 | -$9 | -$7 | -$6 |
| % Margin | -27,056.3% | -3,358% | -2,996.2% | -10,349% |
| Other Income/Exp. Net | $11 | -$0 | $1 | $6 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$9 | -$8 | -$7 |
| % Margin | -31,739.1% | -3,383.8% | -3,332.4% | -11,145.5% |
| EPS | -0.13 | -0.1 | -0.09 | -0.17 |
| % Growth | -30% | -11.1% | 47.1% | – |
| EPS Diluted | -0.13 | -0.1 | -0.09 | -0.17 |
| Weighted Avg Shares Out | 96 | 95 | 94 | 41 |
| Weighted Avg Shares Out Dil | 96 | 95 | 94 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$9 | -$8 | -$6 |
| % Margin | -26,043.2% | -3,197.6% | -3,240.5% | -9,439.7% |